INVESTOR ALERT: Investigation of Osiris Therapeutics, Inc. Announced by Law Offices of Howard G. Smith
May 31 2016 - 2:28PM
Business Wire
Law Offices of Howard G. Smith announces an investigation
on behalf of investors of Osiris Therapeutics, Inc. (“Osiris” or
the “Company”) (NASDAQ: OSIR) concerning the Company and its
officers’ possible violations of federal securities laws.
On May 27, 2016, after the market closed, the Company announced
that it was advised by the United States Attorney’s Office for
the Southern District of New York that the office had opened a
criminal investigation into the Company. Osiris also announced that
it understands the investigation to relate to previously disclosed
matters also under investigation by the SEC.
On this news, shares of Osiris fell approximately 10% during
intra-day trading on May 31, 2016, on unusually heavy trading
volume, thereby injuring investors.
If you purchased Osiris securities, have information or would
like to learn more about these claims, or have any questions
concerning this announcement or your rights or interests with
respect to these matters, please contact Howard G. Smith, Esquire,
of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112,
Bensalem, Pennsylvania 19020 by telephone at (215) 638-4847,
toll-free at (888) 638-4847, or by email
to howardsmith@howardsmithlaw.com, or visit our website at
http://www.howardsmithlaw.com.
This press release may be considered Attorney Advertising in
some jurisdictions under the applicable law and ethical rules.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160531006336/en/
Law Offices of Howard G. SmithHoward G. Smith,
Esquire215-638-4847888-638-4847howardsmith@howardsmithlaw.comwww.howardsmithlaw.com
Osiris Therapeutics, Inc. (NASDAQ:OSIR)
Historical Stock Chart
From Apr 2024 to May 2024
Osiris Therapeutics, Inc. (NASDAQ:OSIR)
Historical Stock Chart
From May 2023 to May 2024